Why does thrombin time increase after taking dabigatran etexilate?

After taking dabigatran etexilate, thrombin time (TT) increases primarily due to the pharmacological effect of the drug. Dabigatran etexilate is a direct thrombin inhibitor that prevents thrombus formation by inhibiting thrombin activity, thereby preventing acute and chronic thromboembolic disorders. As a result of this inhibition, the time required for blood coagulation is prolonged, which manifests as an elevated thrombin time. Specifically, dabigatran etexilate reduces the activity of coagulation factors, helping maintain blood fluidity within vessels and decreasing the likelihood of thrombus formation. However, this may also lead to an increase in thrombin time, since thrombin is a key enzyme in the coagulation cascade, and its inhibited activity directly slows the coagulation process. If you have concerns, consult your physician for further evaluation and monitoring.